Granite Point Capital Management, L.P. - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 133 filers reported holding CHINA BIOLOGIC PRODS INC in Q1 2016. The put-call ratio across all filers is 0.86 and the average weighting 0.4%.

Quarter-by-quarter ownership
Granite Point Capital Management, L.P. ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q1 2017$350,000
-6.9%
3,5000.0%0.10%
-65.0%
Q4 2016$376,000
-77.6%
3,500
-74.1%
0.30%
-54.3%
Q3 2016$1,680,000
-22.9%
13,500
-11.8%
0.66%
+101.2%
Q4 2015$2,180,000
+21.4%
15,300
-23.5%
0.33%
-73.5%
Q3 2015$1,796,000
-46.5%
20,000
-31.4%
1.23%
+26.0%
Q2 2015$3,358,000
-12.1%
29,160
-27.1%
0.98%
-30.2%
Q1 2015$3,820,000
+42.1%
40,0000.0%1.40%
+11.0%
Q4 2014$2,689,000
+42.4%
40,000
+14.3%
1.26%
+34.0%
Q3 2014$1,889,000
+21.4%
35,0000.0%0.94%
-12.2%
Q2 2014$1,556,00035,0001.07%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Ariose Capital Management Ltd 88,655$10,149,0009.57%
WARBURG PINCUS LLC 4,087,200$467,903,0008.91%
RUDMAN ERROL M 64,001$7,327,0004.96%
INDUS CAPITAL PARTNERS, LLC 378,518$43,333,0004.22%
OBERWEIS ASSET MANAGEMENT INC/ 90,105$10,315,0002.98%
Ativo Capital Management LLC 85,623$9,802,0002.66%
Sensato Investors LLC 113,296$12,970,0002.31%
Cormorant Asset Management, LP 111,500$12,765,0001.92%
BARING ASSET MANAGEMENT Ltd 128,784$14,743,0001.23%
Visium Asset Management, LP 484,619$55,479,0000.94%
View complete list of CHINA BIOLOGIC PRODS INC shareholders